Synergy CHC Corp. SNYRQ
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Synergy CHC Corp. is a consumer health and wellness company that has operated in the dietary supplement and over-the-counter consumer healthcare industry. The company became best known for marketing brain health, memory support, and nutritional supplement products, particularly through the FOCUSfactor brand portfolio. Its business model historically centered on product formulation, brand development, retail distribution, and direct consumer marketing across mass retail, pharmacy, grocery, and e-commerce channels.
The company evolved through a series of restructurings, acquisitions, and branding initiatives intended to expand its consumer health platform. Public filings and market disclosures indicate that Synergy CHC pursued growth through brand acquisitions and retail expansion while operating as a publicly traded company in the United States. Trading under the symbol SNYRQ reflects the company’s status associated with bankruptcy or restructuring proceedings. Certain historical operational details and timelines are inconsistent across public market databases and available disclosures; some legacy information remains inconclusive based on available public sources.
Business Operations
Synergy CHC Corp.’s operations historically focused on branded nutritional supplements and consumer wellness products. Its principal revenue driver was the FOCUSfactor product line, which included dietary supplements positioned around cognitive support, memory, concentration, and general wellness. Revenue generation relied on wholesale retail distribution agreements, consumer packaged goods sales, promotional campaigns, and online sales activity. The company also explored adjacent wellness and lifestyle product categories through internal development and acquisitions.
The company’s operations were primarily concentrated in the United States, though products were distributed through national retail chains and digital commerce platforms with broader consumer reach. Public disclosures reference relationships with major retail distributors and commercialization partners within the consumer healthcare sector. Synergy CHC controlled intellectual property associated with its supplement formulations and branding assets, while manufacturing and supply-chain activities appear to have relied substantially on third-party production and contract manufacturing relationships. Data regarding active international subsidiaries or material joint ventures is inconclusive based on available public sources.
Strategic Position & Investments
Synergy CHC Corp.’s strategic direction historically emphasized expansion within the health and wellness market through brand scaling, retail penetration, and acquisitions. A significant strategic asset was the company’s ownership and commercialization of the FOCUSfactor brand, which management positioned as a differentiated cognitive wellness product in a competitive supplement market. Growth initiatives included expanding product variants, increasing retail shelf presence, and leveraging digital marketing channels to build recurring consumer demand.
The company also pursued acquisitions and portfolio diversification efforts intended to broaden its position within consumer healthcare. Public filings and investor materials indicate that Synergy CHC evaluated opportunities across nutritional supplements, wellness products, and consumer packaged health brands. However, financial pressures, liquidity constraints, and restructuring activity ultimately became central factors affecting the company’s trajectory. Information regarding current investment activity, active subsidiaries, or emerging technology initiatives remains limited or inconclusive based on available public disclosures.
Geographic Footprint
Synergy CHC Corp. was headquartered in the United States and primarily operated within the North American consumer health market. Its products were distributed through nationwide retail channels, including pharmacies, supermarkets, warehouse clubs, and e-commerce platforms. The company’s operational footprint appears to have been concentrated domestically, with most reported commercial activity tied to U.S. consumers and retailers.
Although the company’s products may have reached international consumers through online distribution and third-party retail channels, verified evidence of significant direct operational infrastructure outside the United States is limited. Publicly available information does not clearly establish large-scale foreign subsidiaries or material overseas manufacturing ownership. Data regarding current international operational influence is inconclusive based on available public sources.
Leadership & Governance
Synergy CHC Corp. was governed through a conventional public-company leadership structure consisting of executive management and a board of directors. Leadership strategy emphasized brand commercialization, consumer health expansion, and retail distribution growth within the wellness sector. Public company disclosures over time reflected multiple leadership changes associated with acquisitions, restructuring activity, and evolving strategic priorities.
Key executives and leadership figures publicly associated with the company have included:
- Jack Ross – Chief Executive Officer
- Brian McAboy – Chief Financial Officer
- Andrews S. Rudnick – Executive Chairman
Public filings suggest that management’s strategic vision centered on transforming the company into a scalable consumer healthcare platform anchored by branded nutritional products and broader wellness offerings. Certain executive tenure periods and governance details vary across filings and market records; some information is inconclusive based on available public sources.